
Please try another search
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
---|---|---|---|---|---|
Moving Averages | Strong Sell | Sell | Neutral | Strong Buy | Sell |
Technical Indicators | Neutral | Sell | Strong Sell | Strong Buy | Strong Sell |
Summary | Sell | Sell | Sell | Strong Buy | Strong Sell |
Filter Table By:
Pattern | Timeframe | Reliability | Candles Ago | Candle Time | |
---|---|---|---|---|---|
Emerging Patterns | |||||
Bullish Engulfing | 1M | Current | |||
Three Inside Up | 1M | Current | |||
Completed Patterns | |||||
Evening Doji Star | 1W | 4 | Apr 20, 2025 | ||
Falling Three Methods | 1W | 4 | Apr 20, 2025 | ||
Engulfing Bearish | 5H | 4 | May 20, 2025 08:30 |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
---|---|---|---|---|---|---|---|---|---|
IndusInd Bank | 783.85 | 796.70 | 725.80 | +13.90 | +1.81% | 43.48M | 15:29:59 | ||
Bharat Electronics | 383.50 | 386.75 | 379.00 | +0.50 | +0.13% | 43.49M | 15:29:59 | ||
Tata Steel Ltd | 161.50 | 163.60 | 160.36 | -0.14 | -0.09% | 60.69M | 15:29:59 | ||
Dixon Tech | 15,170.00 | 15,592.00 | 15,025.00 | -442.00 | -2.83% | 850.00K | 15:29:59 | ||
SBI | 785.80 | 788.20 | 780.30 | -1.30 | -0.17% | 7.36M | 15:29:59 | ||
DLF | 776.70 | 779.40 | 765.65 | +1.55 | +0.20% | 3.52M | 15:29:57 | ||
Reliance Industries | 1,411.10 | 1,423.80 | 1,396.90 | -18.10 | -1.27% | 12.13M | 15:29:58 | ||
Hindustan Aeronautics | 5,043.00 | 5,064.50 | 4,962.00 | +41.90 | +0.84% | 2.32M | 15:29:59 | ||
HDFC Bank | 1,921.20 | 1,924.20 | 1,905.20 | -5.60 | -0.29% | 10.65M | 15:29:59 | ||
Tata Motors | 718.00 | 725.00 | 710.65 | -8.80 | -1.21% | 10.05M | 15:29:59 |
D. Western Therapeutics Institute, Inc., a biotechnology company, focuses on discovery and development of various drugs. The company offers GLANATEC and GLA-ALPHA, an ophthalmic solution for the treatment of glaucoma/ocular hypertension; DW-1001, an ophthalmic drug; DWR-2206, a regenerative medicine cell-product for bullous keratopathy; and DW-1002, an ophthalmic surgical adjuvant for cataract surgeries, and ILM, ALC, ERM, and PVR membrane staining. It is also developing DW-5LBT, a lidocaine patch for neuropathic pain after shingles; K-321 to treat fuch endothelial corneal dystrophy which is in Phase III clinical trials; and H-1337, a multi-kinase inhibitor that has started Phase IIb clinical trials for the treatment of glaucoma/ocular hypertension. The company was founded in 1999 and is headquartered in Nagoya, Japan.
Read MoreAre you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review